Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-11 · accession 0001055726-22-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-14	2022-03-11	INO	Humeau Laurent	CSO	M - OptEx	—	+59.7K	155.3K	+62%	—
D	2022-03-14	2022-03-11	INO	Humeau Laurent	CSO	F - Tax	$3.22	-20.7K	134.7K	-13%	-$66.5K
D	2022-03-14	2022-03-11	INO	Humeau Laurent	CSO	M - OptEx	$0.00	-59.7K	59.7K	-50%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-11	M	A	59,737	—	155,342	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2	Common	Common Stock	2022-03-11	F	D	20,658	$3.22	134,684	D	—	—
3	Derivative	Restricted Stock Unit	2022-03-11	M	D	59,737	$0.00	59,737	D	— · — to —	59,737 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.